Join
Live feed
·
PRReleasevia Quantisnow
Mural Oncology plc logo
XOMA Royalty Corporation logo

Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty

ByQuantisnow·Wall Street's wire, on your screen.
MURA· Mural Oncology plcXOMA· XOMA Royalty Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MURA (Mural Oncology plc), XOMA (XOMA Royalty Corporation) and more on Quantisnow.